首页> Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology> Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.

Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.

导出 LinkOut

翻译打印收藏纠错

第一作者： Adalbert,Krawczyk

第一单位： Institute of Virology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany.

作者： Adalbert,Krawczyk ^[1] ; Christian,Hintze ^[2] ; Jessica,Ackermann ^[1] ; Birgit,Goitowski ^[1] ; Martin,Trippler ^[3] ; Nico,Grüner ^[1] ; Maria,Neumann-Fraune ^[4] ; Jens,Verheyen ^[5] ; Melanie,Fiedler ^[6]

作者单位： Institute of Virology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany. ^[1] DiaSorin Deutschland GmbH, Von-Hevesy-Str. 3, 63128 Dietzenbach, Germany. ^[2] Department of Gastroenterology and Hepatology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany. ^[3] Institute of Virology, University of Cologne, Fürst-Pückler-Str. 56, 50935 Köln, Germany. ^[4] Institute of Virology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany; Institute of Virology, University of Cologne, Fürst-Pückler-Str. 56, 50935 Köln, Germany. ^[5] Institute of Virology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany. Electronic address: melanie.fiedler@uni-due.de. ^[6]